FILA 2025: Co-founders of Bugworks on their quest for a novel AMR antibiotic

Forbes India - Tech Conversations
05/03/2025 32 min

Listen "FILA 2025: Co-founders of Bugworks on their quest for a novel AMR antibiotic"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode, recorded on January 2, Anand Anandkumar, V Balasubramanian and Santanu Datta, co-founders of Bugworks Research, give us a quick update on their quest for a novel antibiotic to tackle the problem of anti-microbial resistance. The trio, winners of the Forbes India Leadership Award 2025 under the Emerging Innovators category – alongside their Chief Scientist P Shahul Hameed – are also taking a ‘platform approach’ to develop a small molecule that they hope will fight some types of cancer.

More episodes of the podcast Forbes India - Tech Conversations

N Krishnakumar on India’s deep tech landscape, the impact of AI, and Mela’s second fund 30/05/2025
Jaicky Kumar and Deepak Mishra on their thermal storage innovation at Voltanova Energy 02/05/2025
Amit Gupta on Yulu’s opportunity to ride the quick commerce wave 25/03/2025
Founders of Rapid Claims on their conviction in building AI products from India 19/03/2025
Brijraj Bhuptani on early US growth and lessons from focusing on outcomes first at Spry 12/03/2025
Khadim Batti and Alok Goyal on Whatfix’s roadmap to IPO in two years 10/02/2025
Accel’s Anand Daniel and Prayank Swaroop on the next decade of Indian startups 21/01/2025
Why these VCs at Ankur Capital hope to see deep tech playbooks in India in 2025 06/01/2025
Founder’s mode: What Aneesh Reddy at Capillary Technologies looks for in a CEO 18/12/2024
Climate resilient water conservation: Lessons for India from a project in Bengaluru 05/12/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA